Sebastien Carnicella - Publications

Affiliations: 
Ernest Gallo Clinic and Research Center, UCSF, San Francisco, CA, United States 
Area:
Fear Conditioning, Addiction, Alcohol

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Magnard R, Fouyssac M, Vachez YM, Cheng Y, Dufourd T, Carcenac C, Boulet S, Janak PH, Savasta M, Belin D, Carnicella S. Pramipexole restores behavioral inhibition in highly impulsive rats through a paradoxical modulation of frontostriatal networks. Translational Psychiatry. 14: 86. PMID 38336862 DOI: 10.1038/s41398-024-02804-3  0.561
2022 Goutaudier R, Joly F, Mallet D, Bartolomucci M, Guicherd D, Carcenac C, Vossier F, Dufourd T, Boulet S, Deransart C, Chovelon B, Carnicella S. Hypodopaminergic state of the nigrostriatal pathway drives compulsive alcohol use. Molecular Psychiatry. PMID 36376463 DOI: 10.1038/s41380-022-01848-5  0.329
2022 Favier M, Carcenac C, Savasta M, Carnicella S. Dopamine D3 Receptors: A Potential Target to Treat Motivational Deficits in Parkinson's Disease. Current Topics in Behavioral Neurosciences. PMID 35469394 DOI: 10.1007/7854_2022_316  0.309
2020 Goutaudier R, Coizet V, Carcenac C, Carnicella S. Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats. Plos One. 15: e0238156. PMID 32946510 DOI: 10.1371/Journal.Pone.0238156  0.306
2020 Vachez Y, Carcenac C, Magnard R, Goff LK, Salin P, Savasta M, Carnicella S, Boulet S. Reply to: Letter to the Editor by Martínez-Fernández. Movement Disorders : Official Journal of the Movement Disorder Society. 35: 1084-1085. PMID 32562462 DOI: 10.1002/Mds.28082  0.689
2020 Vachez Y, Carcenac C, Magnard R, Kerkerian-Le Goff L, Salin P, Savasta M, Carnicella S, Boulet S. Subthalamic nucleus stimulation impairs motivation: Implication for apathy in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31930749 DOI: 10.1002/Mds.27953  0.733
2020 Neasta J, Darcq E, Jeanblanc J, Carnicella S, Ben Hamida S. GPCR and Alcohol-Related Behaviors in Genetically Modified Mice. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 31919661 DOI: 10.1007/S13311-019-00828-Y  0.761
2018 Magnard R, Vachez Y, Carcenac C, Boulet S, Houeto JL, Savasta M, Belin D, Carnicella S. Nigrostriatal Dopaminergic Denervation Does Not Promote Impulsive Choice in the Rat: Implication for Impulse Control Disorders in Parkinson's Disease. Frontiers in Behavioral Neuroscience. 12: 312. PMID 30618665 DOI: 10.3389/Fnbeh.2018.00312  0.753
2017 Delpont B, Lhommée E, Klinger H, Schmitt E, Bichon A, Fraix V, Castrioto A, Quesada JL, Pélissier P, Kistner A, Carnicella S, Lüscher C, Broussolle E, Pollak P, Thobois S, et al. Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28737225 DOI: 10.1002/Mds.27101  0.381
2017 Favier M, Carcenac C, Drui G, Vachez Y, Boulet S, Savasta M, Carnicella S. Implication of dorsostriatal D3 receptors in motivational processes: a potential target for neuropsychiatric symptoms in Parkinson's disease. Scientific Reports. 7: 41589. PMID 28134302 DOI: 10.1038/Srep41589  0.396
2016 Houeto JL, Magnard R, Dalley JW, Belin D, Carnicella S. Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease? Frontiers in Psychiatry. 7: 91. PMID 27303314 DOI: 10.3389/Fpsyt.2016.00091  0.745
2016 Castrioto A, Thobois S, Carnicella S, Maillet A, Krack P. Emotional manifestations of PD: Neurobiological basis. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27041545 DOI: 10.1002/Mds.26587  0.338
2016 Magnard R, Vachez Y, Carcenac C, Krack P, David O, Savasta M, Boulet S, Carnicella S. What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease? Translational Psychiatry. 6: e753. PMID 26954980 DOI: 10.1038/Tp.2016.17  0.36
2015 Sierra M, Carnicella S, Strafella AP, Bichon A, Lhommée E, Castrioto A, Chabardes S, Thobois S, Krack P. Apathy and Impulsive Control Disorders: Yin & Yang of Dopamine Dependent Behaviors. Journal of Parkinson's Disease. PMID 25870025 DOI: 10.3233/Jpd-150535  0.391
2015 Carcenac C, Favier M, Vachez Y, Lacombe E, Carnicella S, Savasta M, Boulet S. Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 25588931 DOI: 10.1002/Mds.26146  0.327
2014 Carnicella S, Drui G, Boulet S, Carcenac C, Favier M, Duran T, Savasta M. Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits. Translational Psychiatry. 4: e401. PMID 24937095 DOI: 10.1038/Tp.2014.43  0.393
2014 Carnicella S, Ron D, Barak S. Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse. Alcohol (Fayetteville, N.Y.). 48: 243-52. PMID 24721195 DOI: 10.1016/J.Alcohol.2014.01.006  0.712
2014 Favier M, Duran T, Carcenac C, Drui G, Savasta M, Carnicella S. Pramipexole reverses Parkinson's disease-related motivational deficits in rats. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 912-20. PMID 24515412 DOI: 10.1002/Mds.25837  0.431
2014 Drui G, Carnicella S, Carcenac C, Favier M, Bertrand A, Boulet S, Savasta M. Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease. Molecular Psychiatry. 19: 358-67. PMID 23399912 DOI: 10.1038/Mp.2013.3  0.368
2012 Ben Hamida S, Neasta J, Lasek AW, Kharazia V, Zou M, Carnicella S, Janak PH, Ron D. The small G protein H-Ras in the mesolimbic system is a molecular gateway to alcohol-seeking and excessive drinking behaviors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 15849-58. PMID 23136424 DOI: 10.1523/Jneurosci.2846-12.2012  0.686
2012 Wang J, Ben Hamida S, Darcq E, Zhu W, Gibb SL, Lanfranco MF, Carnicella S, Ron D. Ethanol-mediated facilitation of AMPA receptor function in the dorsomedial striatum: implications for alcohol drinking behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 15124-32. PMID 23100433 DOI: 10.1523/Jneurosci.2783-12.2012  0.725
2012 Lhommée E, Klinger H, Thobois S, Schmitt E, Ardouin C, Bichon A, Kistner A, Fraix V, Xie J, Aya Kombo M, Chabardès S, Seigneuret E, Benabid AL, Mertens P, Polo G, ... Carnicella S, et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. Brain : a Journal of Neurology. 135: 1463-77. PMID 22508959 DOI: 10.1093/Brain/Aws078  0.329
2011 Barak S, Carnicella S, Yowell QV, Ron D. Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seeking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 9885-94. PMID 21734280 DOI: 10.1523/Jneurosci.1750-11.2011  0.715
2011 Neasta J, Ben Hamida S, Yowell QV, Carnicella S, Ron D. AKT signaling pathway in the nucleus accumbens mediates excessive alcohol drinking behaviors. Biological Psychiatry. 70: 575-82. PMID 21549353 DOI: 10.1016/J.Biopsych.2011.03.019  0.582
2011 Carnicella S, Yowell QV, Ron D. Regulation of operant oral ethanol self-administration: a dose-response curve study in rats. Alcoholism, Clinical and Experimental Research. 35: 116-25. PMID 21039633 DOI: 10.1111/J.1530-0277.2010.01328.X  0.569
2010 Neasta J, Ben Hamida S, Yowell Q, Carnicella S, Ron D. Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders. Proceedings of the National Academy of Sciences of the United States of America. 107: 20093-8. PMID 21041654 DOI: 10.1073/Pnas.1005554107  0.57
2010 Carnicella S, He DY, Yowell QV, Glick SD, Ron D. Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration. Addiction Biology. 15: 424-33. PMID 21040239 DOI: 10.1111/J.1369-1600.2010.00251.X  0.602
2010 Wang J, Carnicella S, Ahmadiantehrani S, He DY, Barak S, Kharazia V, Ben Hamida S, Zapata A, Shippenberg TS, Ron D. Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 14502-12. PMID 20980608 DOI: 10.1523/Jneurosci.3909-10.2010  0.751
2010 Wang J, Lanfranco MF, Gibb SL, Yowell QV, Carnicella S, Ron D. Long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsomedial striatum play a crucial role in alcohol consumption and relapse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 10187-98. PMID 20668202 DOI: 10.1523/Jneurosci.2268-10.2010  0.576
2010 Carnicella S, Mongeot A, Bourguignon JJ, Oberling P. Prefrontal cortex and reversion of atropine-induced disruption of the degraded contingency effect by antipsychotic agents and N-desmethylclozapine in rats. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 109-22. PMID 19531280 DOI: 10.1017/S1461145709990095  0.661
2009 Jeanblanc J, He DY, Carnicella S, Kharazia V, Janak PH, Ron D. Endogenous BDNF in the dorsolateral striatum gates alcohol drinking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 13494-502. PMID 19864562 DOI: 10.1523/Jneurosci.2243-09.2009  0.771
2009 Carnicella S, Ahmadiantehrani S, Janak PH, Ron D. GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence. Alcoholism, Clinical and Experimental Research. 33: 1012-24. PMID 19302086 DOI: 10.1111/J.1530-0277.2009.00922.X  0.759
2009 Carnicella S, Ahmadiantehrani S, He DY, Nielsen CK, Bartlett SE, Janak PH, Ron D. Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor. Biological Psychiatry. 66: 146-53. PMID 19232578 DOI: 10.1016/J.Biopsych.2008.12.022  0.772
2009 Carnicella S, Amamoto R, Ron D. Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor. Alcohol (Fayetteville, N.Y.). 43: 35-43. PMID 19185208 DOI: 10.1016/J.Alcohol.2008.12.001  0.602
2009 Carnicella S, Ron D. GDNF--a potential target to treat addiction. Pharmacology & Therapeutics. 122: 9-18. PMID 19136027 DOI: 10.1016/J.Pharmthera.2008.12.001  0.503
2008 Carnicella S, Kharazia V, Jeanblanc J, Janak PH, Ron D. GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proceedings of the National Academy of Sciences of the United States of America. 105: 8114-9. PMID 18541917 DOI: 10.1073/Pnas.0711755105  0.784
2007 Wang J, Carnicella S, Phamluong K, Jeanblanc J, Ronesi JA, Chaudhri N, Janak PH, Lovinger DM, Ron D. Ethanol induces long-term facilitation of NR2B-NMDA receptor activity in the dorsal striatum: implications for alcohol drinking behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3593-602. PMID 17392475 DOI: 10.1523/Jneurosci.4749-06.2007  0.787
2006 Carnicella S, de Vasconcelos AP, Pain L, Majchrzak M, Oberling P. Fos immunolabelling evidence for brain regions involved in the Pavlovian degraded contingency effect and in its disruption by atropine. Neuropharmacology. 51: 102-11. PMID 16678862 DOI: 10.1016/J.Neuropharm.2006.03.005  0.667
2005 Carnicella S, Pain L, Oberling P. Cholinergic effects on fear conditioning II: nicotinic and muscarinic modulations of atropine-induced disruption of the degraded contingency effect. Psychopharmacology. 178: 533-41. PMID 15696332 DOI: 10.1007/S00213-004-2101-6  0.668
2005 Carnicella S, Pain L, Oberling P. Cholinergic effects on fear conditioning I: the degraded contingency effect is disrupted by atropine but reinstated by physostigmine. Psychopharmacology. 178: 524-32. PMID 15696319 DOI: 10.1007/S00213-005-2176-8  0.667
Show low-probability matches.